Clinical trial
Pain Relief Investigation of Neuromodulation Therapy in an Adult Fibromyalgia…
NCT00450905 · Fralex Therapeutics, Industry · Terminated
Key facts
| NCT number | NCT00450905 |
|---|---|
| Title | Pain Relief Investigation of Neuromodulation Therapy in an Adult Fibromyalgia Population |
| Official title | Randomized Evaluation of a Low-Frequency Investigational Device Employing Neuromodulation Therapy in Patients With Fibromyalgia |
| Lead sponsor | Fralex Therapeutics, Industry |
| Collaborators | PharmaNet Industry McDougall Scientific Limited |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fibromyalgia, Pain |
| Intervention type | Device |
| Interventions | PRIMA Device |
| Enrollment | 200 |
| Start date | Mar 1, 2007 |
| Completion | Dec 1, 2008 |
| First posted | Mar 22, 2007 |
| Last update posted | Oct 6, 2008 |
| Countries | Canada, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: